BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20368050)

  • 1. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary studies on cell derivation of neovascularization in human glioma and its functional evaluation].
    Fei XF; Zhang QB; Dong J; Wang AD; Wang ZM; Huang Q
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):726-31. PubMed ID: 22335902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 identifies perivascular niches in grade II-IV astrocytomas.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors].
    Deng YW; Fang JS; Li MC; Chen FH; Zhou XY; Wu J; Zhou RH; Fang F; Chen C; Lu M; Zeng FY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):45-51. PubMed ID: 16562674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glial stem cells and their relationship with tumour angiogenesis process].
    Bulnes S; García-Blanco Á; Bengoetxea H; Ortuzar N; Argandoña EG; Lafuente JV
    Rev Neurol; 2011 Jun; 52(12):743-50. PubMed ID: 21594859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
    Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
    Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
    Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
    He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K.
    Hira VV; Ploegmakers KJ; Grevers F; Verbovšek U; Silvestre-Roig C; Aronica E; Tigchelaar W; Turnšek TL; Molenaar RJ; Van Noorden CJ
    J Histochem Cytochem; 2015 Jul; 63(7):481-93. PubMed ID: 25809793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
    Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
    Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.